Findings of a South Korean study suggest ultrasound is an effective way to monitor lymph node recurrence after breast cancer surgery.
Findings of a South Korean study suggest ultrasound is an effective way to monitor lymph node recurrence after breast cancer surgery.
Dr. Hee Jung Moon and colleagues at the Research Institute of Radiological Science in Seoul assessed 1817 patients imaged with ultrasound; 2.1% had lymph node recurrence and findings were confirmed by cytopathology, clinical follow-up, and imaging (Radiology 2009;252:673-681). Ultrasound sensitivity was 76.9% and specificity was 98.7%. Distant metastases were found more frequently in patients with ipsilateral recurrence (62%) than in those without (2.3%). Regional lymph node recurrence affects less than a fifth of patients with any stage of breast cancer but is difficult to manage and associated with poor prognosis.
Mammography Study Suggests DBT-Based AI May Help Reduce Disparities with Breast Cancer Screening
December 13th 2024New research suggests that AI-powered assessment of digital breast tomosynthesis (DBT) for short-term breast cancer risk may help address racial disparities with detection and shortcomings of traditional mammography in women with dense breasts.
Mammography News: FDA Grants Expanded 510(k) Clearance for AI-Powered SmartMammo Dx DBT Software
November 29th 2024Originally cleared by the FDA in 2021, the SmartMammo Dx software for digital breast tomosynthesis (DBT) can now be utilized with the Senographe Pristina mammography systems from GE HealthCare.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.